How Big is the Point-of-Care Diagnostics Market? $18 Billion and Climbing

Our new report finds lots of activity and opportunity in near patient testing. The POC diagnostic industry is part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine as emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are transforming the POC landscape. New technologies are making the concept more viable than ever.


POC IVD a Viable Business Model for Theranos

POC IVD a Viable Business Model for Theranos

Intrigue regarding stealthy diagnostics and lab testing company Theranos has given way to controversy as recent reports and allegations question the efficacy of the company’s core technology. Theranos recently disclosed that the fingerstick sampling method used in conjunction with its in-house developed IVD analyzer, referred to as ‘Edison’ in reports, is now limited to only one test, a FDA-approved laboratory developed test (LDT) for herpes simplex virus-1 (HSV-1). The reduced role of Theranos’...


New Developments in Point-of-Care (POC) Diagnostics - Kalorama White Paper

New Developments in Point-of-Care (POC) Diagnostics - Kalorama White Paper

This post was adapted from a recently released Kalorama Information white paper on clinical point-of-care diagnostics. To receive the white paper, contact a customer service representative at 1-800-298-5603 (intl. +1 240 747 3096) or customerservice@kaloramainformation.com to register your company for free at www.kaloramainformation.com. For additional current and authoritative analysis of the POC diagnostics market, consult Kalorama Information’s market research report The World Market for Poin...


Top Five IVD Segments in the United States - Leaders in Forecast Growth

Top Five IVD Segments in the United States - Leaders in Forecast Growth

( This post represents the fourth installment of a weekly preview of Kalorama Information’s upcoming publication - The US Market for In Vitro Diagnostic Tests - for March 2014. The posts review the projected top-performing IVD segments in the U.S. market through 2018. )

The United States is the most mature and diversified IVD market in the world, with many clinical tests first developed and approved in the country and most core testing segments already at market saturation. Established market ...